|By Business Wire||
|October 19, 2016 03:00 PM EDT|
Science Exchange and SolveBio announce that SolveBio will be listed on Science Exchange to bring their cutting-edge translational medicine software solution to pharmaceutical and biotech companies around the world. SolveBio enables pharmaceutical, biotech, and CDx R&D teams to maintain a real-time, collaborative, in-depth view into targets, biomarkers, and clinical trials and effectively use molecular knowledge. The listing of SolveBio strengthens Science Exchange’s market-leading position as the most important way to bring innovative scientific services to early stage drug development.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161019006095/en/
“We are very excited to be developing a strategic relationship with Science Exchange and to work with their outsourced marketplace for scientific research”, said Mark Kaganovich, CEO of SolveBio, “We firmly believe that our relationship with Science Exchange will streamline and expedite the process by which customers deploy SolveBio technology and we look forward to working with our colleagues at Science Exchange”. SolveBio helps life science companies monitor and integrate intelligence generated by internal teams, collaborators, and external feeds in real-time to adopt a truly translational approach to the development of therapeutics and diagnostics.
“Science Exchange is pleased to offer the services of SolveBio through our marketplace and concierge service”, said Elizabeth Iorns, CEO of Science Exchange. “Our pharma and biotech customers look to us to add innovation to their scientific initiatives and SolveBio is one more way to do that. This can move their research forward.” Science Exchange is the easiest way to access new innovative service providers because of our pre-established contracts in place and pre-qualification of all service providers. Through one MSA, companies have instant access to our service providers which now includes SolveBio.
SolveBio’s storefront is available on the Science Exchange marketplace and ready for ordering. You can also contact Science Exchange’s Concierge Service to request the services of SolveBio. The Concierge Service offering from Science Exchange consists of a dedicated scientist with a master’s degree or PhD that will identify the most qualified service providers for your project.
About Science Exchange:
Since its founding in 2011, Science Exchange has become the world’s leading marketplace for scientific research. Through Science Exchange, researchers can securely access a network of 1,000s of screened and verified contract research organizations (CROs), academic labs, and government facilities that are available to conduct scientific experiments. Science Exchange has been used by researchers from over 2,500 different companies and organizations, including many large pharmaceutical companies and government research facilities like the NIH, the FDA, and NASA. The company’s mission is to enable breakthrough scientific discoveries by providing researchers with easy access to the world’s best service providers. To date, the company has raised over $30 million from Maverick Capital Ventures, Union Square Ventures, Index Ventures, OATV, the YC Continuity Fund, and others. For more information visit www.scienceexchange.com.
SolveBio was founded in 2013 with the mission of building a cutting-edge Translational medicine solution. In partnership with some of the leading pharmaceutical, diagnostics, and CDx organizations in the world, SolveBio has developed technology to enable the use of multi-omics and clinical outcomes data for therapeutic and diagnostic development. SolveBio’s core technology allows it to index, harmonize, and link complex biological data in real-time: external data sources are continuously processed and connected to proprietary internal customer information. This allows biotech, pharma, and diagnostic customers to maintain a real-time, collaborative, in-depth view into targets, biomarkers, and clinical trials and effectively use molecular knowledge. SolveBio is based in New York and has raised $4.5M to date, from Andreessen Horowitz, Max Levchin, Faridan Ventures, Nat Turner, and other leading technology and life sciences investors.
Oct. 23, 2016 07:00 AM EDT Reads: 4,091
Oct. 23, 2016 06:30 AM EDT Reads: 4,734
Oct. 23, 2016 06:15 AM EDT Reads: 16,339
Oct. 23, 2016 06:00 AM EDT Reads: 677
Oct. 23, 2016 05:30 AM EDT Reads: 3,919
Oct. 23, 2016 05:15 AM EDT Reads: 1,834
Oct. 23, 2016 04:45 AM EDT Reads: 4,334
Oct. 23, 2016 04:00 AM EDT Reads: 3,919
Oct. 23, 2016 03:45 AM EDT Reads: 3,304
Oct. 23, 2016 03:45 AM EDT Reads: 1,693
Oct. 23, 2016 03:30 AM EDT Reads: 2,952
Oct. 23, 2016 03:30 AM EDT Reads: 1,442
Oct. 23, 2016 03:00 AM EDT Reads: 1,272
SYS-CON Events announced today that Streamlyzer will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Streamlyzer is a powerful analytics for video streaming service that enables video streaming providers to monitor and analyze QoE (Quality-of-Experience) from end-user devices in real time.
Oct. 23, 2016 02:30 AM EDT Reads: 941
SYS-CON Media announced today that @WebRTCSummit Blog, the largest WebRTC resource in the world, has been launched. @WebRTCSummit Blog offers top articles, news stories, and blog posts from the world's well-known experts and guarantees better exposure for its authors than any other publication. @WebRTCSummit Blog can be bookmarked ▸ Here @WebRTCSummit conference site can be bookmarked ▸ Here
Oct. 23, 2016 02:30 AM EDT Reads: 9,649